Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule: Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.)
Vittorio Gebbia(Università degli Studi di Enna Kore), Ferdinando Riccardi(Ospedale Antonio Cardarelli), Santo Fortunato(Indiana University Bloomington), Francesco Giotta(Istituto Tumori Bari), Serravezza Giuseppe(Ospedale Santa Chiara), Giuseppe Colucci, Antonio Testa(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Nicolo' Gebbia(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Evaristo Majello(Radiation Oncology Institute), Giuseppe Pezzella(Ospedale SS. Annunziata)
Cited by 53
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Science of science
|Science|2018|1.4k
Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial
|JNCI Journal of the National Cancer Institute|2003|795
Diffusion of scientific credits and the ranking of scientists
|Physical Review E|2009|330
Characterizing and Modeling the Dynamics of Online Popularity
|Physical Review Letters|2010|257